IJSER Home >> Journal >> IJSER
International Journal of Scientific and Engineering Research
ISSN Online 2229-5518
ISSN Print: 2229-5518 7    
Website: http://www.ijser.org
scirp IJSER >> Volume 2, Issue 7, July 2011 Edition
Indigenous resource usage in the pharmaceuticals industry in Bangladesh: A Descriptive Approach To Explain The Industry Scopes
Full Text(PDF, 3000)  PP.  
Md. Ariful Islam, Md. Nazmul Huda, Anzir Mahmud, S M Mazharul Islam
pharmaceuticals, pharmaceuticals scopes, Bangladesh, indigenous resource, pharmaceutical resources, pharmaceutical export-import, research and innovation
Whether there is any framework or not, sometimes businesses grow and run into an economy. After a matured stage, the community starts developing the industry for their own good. Bangladesh has a very competitive market inside and also outside from its own pharmaceuticals industry, even where multinational organizations are facing many challenges to compete with local organizations. But in this matured stage how much indigenous technology they could reveal out from the system. Students are getting out from universities, but they're not learning how to develop through research. They are becoming just operational workers. But through incubation and better investment, this situation can be improved. Besides this another threat is coming nearby to this industry. Patent rights valuation will make the local organizations weaker just because they are compounding the resources ignoring investments into molecule development. Several Active Pharmaceuticals Ingredients (APIs) are being produced here, but not in that large scale. To cope up with this situation government and DDA should come up some strategic plans to stand against future threats.
[1] Directorate of Drug Administration, Bangladesh (http://www.ddabd.org/)

[2] Nabi, Md. Noor Un and Dornberger, Utz, “Emergence of Industry and Insufficient Institutions – Development of the Generic Pharmaceuticals Industry in Bangladesh”, 2010

[3] Bobhate, Shailendra, “Open for Trade – Bangladesh offers fertile ground for Zuellig Pharma’s distribution ambition in South Asia”, The Market Partner (Zuellig Pharma Asia Pacific), pp.14-17, Issue 48 | April 2010

[4] World Bank Data Bank (http://databank.worldnank.org/)

[5] Gehl Sampath, P., “Innovation and Competitive Capacity in Bangladesh’s Pharmaceuticals Sector”, UNU-MERIT Working Paper No. 2007- 031, United Nations University (UNU) – Maastricht Economic and Social Research and training center on Innovation and Technology (MERIT), The Netherlands, 2007

[6] Azad, Abul K., “Bangladesh Pharmaceutical Sector: Present and Potential”, BAPA Journal, July 2006

[7] Bangladesh Bank Export-Import Data (http://www.bangladeshbank. org/)

[8] Foreign Trade Statistics of Bangladesh Reports, Bangladesh Bureau of Statistics (http://www.bbs.gov.bd/)

[9] Human Development Unit, South Asia Region, The World Bank, “Public and Private Sector Approaches to Improving Pharmaceuticals Quality in Bangladesh”, Bangladesh Development Series (Paper No. 23), March 2008

[10] Trade Programme, Division Economic Development and Employment, Division Agriculture, Fisheries and Food, GTZ, Study on the Viability of High Quality Drug Manufacturing in Bangladesh, 2007

Untitled Page